Circular Genomics launches antidepressant response test

Katelyn Trinh
Sep 17, 2024
1 min read

The new SSRI antidepressant test uses circular RNA biomarkers to improve precision in psychiatry.

Circular Genomics has introduced MindLight, a test designed to predict the response of patients with depression to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.

View remaining article on Medical Device Network

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

bottom of page